Merck (MRK) Total Debt (2009 - 2026)

Merck (MRK) has 18 years of Total Debt data on file, last reported at $49.1 billion in Q1 2026.

• Total Debt for Q1 2026 came in at $49.1 billion, up 40.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.1 billion (up 40.96% YoY), and the FY2025 annual result was $49.3 billion, up 32.95% from the prior year.
• Total Debt steadied at $49.1 billion in Q1 2026 per MRK's latest filing, from $49.3 billion in the prior quarter.
• Over five years, Total Debt peaked at $49.3 billion in Q4 2025 and troughed at $30.4 billion in Q3 2022.
• A 5-year average of $36.4 billion and a median of $35.1 billion in 2023 frame the typical range for Total Debt.
• The sharpest annual moves came in 2022 and 2026: Total Debt retreated 7.28% in 2022, then jumped 40.96% in 2026.
• A 5-year view of Total Debt shows it stood at $30.7 billion in 2022, then climbed by 14.22% to $35.1 billion in 2023, then increased by 5.87% to $37.1 billion in 2024, then soared by 32.95% to $49.3 billion in 2025, then declined by 0.45% to $49.1 billion in 2026.
• Business Quant data shows MRK's Total Debt at $49.1 billion in Q1 2026, $49.3 billion in Q4 2025, and $41.4 billion in Q3 2025.